| Literature DB >> 36152161 |
Faith Christine Harvey1,2, Anddre Osmar Valdivia1,2, Colin Hayter3, Sanjoy K Bhattacharya4,5.
Abstract
Multiple sclerosis is a demyelinating disease of the central nervous system characterized by the loss of the myelin sheath-the nonconductive membrane surrounding neuronal axons. Demyelination interrupts neuronal transmission, which can impair neurological pathways and present a variety of neurological deficits. Prolonged demyelination can damage neuronal axons resulting in irreversible neuronal damage. Efforts have been made to identify agents that can promote remyelination. However, the assessment of remyelination that new therapies promote can be challenging. The method described in this chapter addresses this challenge by using isobaric C13-histidine as a tag for monitoring its incorporation into myelin proteins and thus monitoring the remyelination process.Entities:
Keywords: C13-histidine; Demyelinating disease; EAE mouse model; Isobaric labeling; Mass spectrometry; Proteomics; Remyelination
Mesh:
Substances:
Year: 2023 PMID: 36152161 DOI: 10.1007/978-1-0716-2699-3_17
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745